Abstract:Objective To evaluate the feasibility of using endoscopic sentinel lymph node biopsy (SLNB) in surveying metastasis of cancer cells to axillary lymph nodes in patients with breast cancer after neoadjuvant chemotherapy (NAC) by means of combined methylene blue and 99Tcm-sulfur colloid tracing. Methods Forty-one patients with breast cancer, who preoperatively received neoadjuvant chemotherapy for 2-4 courses, underwent endoscopic SLNB. 99Tcm-sulfur colloid (0.5-1.0mCi) was peritumoral injected at 4 sites 15-18 hours before operation. and 4-6 ml methylene blue was subcutaneously injected at the same sites during operation. Locations of nuclide-enriched lymph nodes, detected with a hand-held gamma probe, were marked on skin of patients using indelible ink. Liposuction was performed after injection of lipolytic solution into axillary space, and the SLNs were identified with endoscopy, and complete endoscopic axillary lymph node dissection (EALND) was performed. Positive metastasis was defined when tumor cells were histopathologically found in lymph nodes. For those lymph nodes designated as "sentinel node" without tumor cell metastasis microscopically, an additional immunohistochemical stainning for CK19 was carried out. The accuracy, sensitivity, specificity, false negative rate and false positive rate of axillary lymph nodes metastasis were calculated. Results A total of 126 SLNs were obtained and examined from 39 of 41 patients (95.12%), with an average of 3.07 SLNs per case. The true-positive metastasis was found in 18 cases, true-negative results in 20 cases, and false-negative result in 1 case. The accuracy of prediction of metastasis to axilliary lymph nodes was 97.43%, sensitivity was 94.74%, specificity was 100%, false negative rate was 5.26%, and false positive rate was 0%. Immunohistochemical detection revealed that there was positive expression of CK19 in a patient in whom the previous pathological determination showed negative SLNs metastasis. All patients were satisfactory with the cosmetic result after SLNB. Conclusions The combined use of methylene blue and 99Tcm-sulfur colloid tracing in endoscopic SLNB may increase the detection rate of SLN, and has the advantages of minimal invasion and satisfactory cosmetic result. The axillary sentinel lymph node metastasis can be accurately identified by the combined use of two tracing agents in breast cancer patients after neoadjuvant chemotherapy.

Evaluation on feasibility of sentinel lymph node biopsy in breast cancer patients after neoadj uvant chemotherapy

High Risk For Non-Sentinel Node Metastasis In Breast Cancer Patients With Sentinel Node Metastases

Research Progress of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer

Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Clinically Node-Positive Breast Cancer after Neoadjuvant Chemotherapy: A Meta-Analysis

Sentinel lymph node biopsy in patients with operable breast cancer after neoadjuvant systemic therapy

Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Retrospective Comparative Evaluation of Clinically Axillary Lymph Node Positive and Negative Patients, Including Those with Axillary Lymph Node Metastases Confirmed by Fine Needle Aspiration

Endoscopic sentinel lymph node biopsy with combined methylene blue and ~(99)Tc~m-sulfur colloid tracing in patients with breast cancer after neoadjuvant chemotherapy (a report of 41 cases)

Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy

[Detection of Sentinel Lymph Node in Patients with Early Stage Breast Cancer].

Efficacy of sentinel lymph-node biopsy after neoadjuvant chemotherapy in clinically axilla node-negative patients

Sentinel Lymph Node Biopsy after Neoadjuvant Treatment for Breast Cancer. The Validation Protocol

Is Sentinel Lymph Node Biopsy a Viable Alternative to Axillary Lymph Node Dissection in Breast Carcinoma Patients Who Have Received Neo-Adjuvant Chemotherapy?

The clinical application of sentinel lymph node biopsy replacing axillary lymph node dissection in breast cancer

Adding carbon nanoparticles to dual-tracers for the sentinel node evaluation after neoadjuvant chemotherapy in patients with pretreatment node-positive breast cancers: The TT-SLNB trial.

[Detection of Sentinel Lymph Node in Patients with Breast Cancer].

Clep_a_264349 917..924

Sentinel lymph node biopsy for breast cancer: a result of 126 cases

Application of a Carbon Nanoparticle Suspension for Sentinel Lymph Node Mapping in Patients with Early Breast Cancer: a Retrospective Cohort Study.

Study of sentinel lymph node biopsy in directing selective axillary lymph node dissection in patients receiving breast-conserving therapy

Sentinel lymph node biopsy for T1 breast cancer (A report of 41 cases)

The Detection and Clinical Significance of Sentinel Lymph Node Biopsy in Breast Cancer